Join the Psoriasis group to help and get support from people like you.
Psoriasis News
Related terms: Erythrodermic Psoriasis, Guttate Psoriasis, Inverse Psoriasis, Palmo-plantar Psoriasis, Psoriasis vulgaris, Pustular Psoriasis
Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment Insights
MONDAY, May 13, 2024 – Psoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal...
Tobacco Smoking Reduces the Odds of Psoriasis Improvement
WEDNESDAY, April 24, 2024 – Tobacco smoking is negatively associated with resolution of psoriasis symptoms, according to a study published in the April issue of Tobacco Induced Diseases. Yan Qiang,...
Kids With Common Skin Conditions Face Stigma, Bullying
WEDNESDAY, April 24, 2024 – Acne, psoriasis, eczema, vitiligo, alopecia: Any one of these common skin ailments can render a child vulnerable to stigma and bullying at school, new research confirms....
Mouse Study Yields Clues to Why Psoriasis Worsens
MONDAY, March 25, 2024 – Australian researchers say they have identified a gene mutation that causes the skin disease psoriasis. A chronic inflammatory condition, psoriasis causes red, scaly, itchy...
FDA Approves Expanded Generalized Pustular Psoriasis Indications for Spevigo
Ingelheim, Germany, March 19, 2024 – Boehringer Ingelheim today announced that the US Food and Drug Administration (FDA) has approved Spevigo (spesolimab-sbzo) injection for the treatment of...
AAD: Bimekizumab Response Durable at Four Years for Moderate-to-Severe Psoriasis
FRIDAY, March 15, 2024 -- Patients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, ...
Tacrolimus Microemulsion Has Good Efficacy, Safety for Scalp Psoriasis
TUESDAY, March 5, 2024 – For scalp psoriasis, 0.1 percent tacrolimus microemulsion has good efficacy and safety, according to a study published online Feb. 12 in Dermatology and Therapy. Andreas...
Deep Learning Improves Diagnostic Accuracy for Skin Diseases
FRIDAY, Feb. 16, 2024 – Deep learning-aided decision support improves diagnostic accuracy for skin disease, according to a study published online Feb. 5 in Nature Medicine. Matthew Groh, Ph.D., from...
JNJ-77242113 Shows Greater Efficacy Than Placebo for Plaque Psoriasis
THURSDAY, Feb. 8, 2024 – For patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study...
Biological Agent Trials for Psoriasis Rarely Include Patient Images
FRIDAY, Dec. 29, 2023 – Few randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online Nov. 15 in the Journal of...
Skin Conditions Flare Up When Wildfires Nearby
TUESDAY, Dec. 26, 2023 – The smoke billowing from this summer’s devastating wildfires wasn’t just bad for your lungs. Skin problems also seem to worsen, with dermatology visits rising as air quality ...
Skin Diseases Pose a Psychosocial Burden
THURSDAY, Nov. 2, 2023 – Skin diseases can cause a psychosocial burden and feelings of stigmatization, according to a study published online Oct. 8 in the Journal of the European Academy of ...
FDA Approves Arcutis’ Zoryve (roflumilast) Cream 0.3% for Treatment of Psoriasis in Children Ages 6 to 11
WESTLAKE VILLAGE, Calif., Oct. 06, 2023 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful i...
Coronary Microvascular Dysfunction ID'd in 31.5 Percent With Psoriasis
WEDNESDAY, Sept. 20, 2023 – Coronary microvascular dysfunction (CMD) occurs in 31.5 percent of patients with psoriasis, with disease severity and duration associated with increased risk, according...
Is It Eczema or Psoriasis? An Expert Offers Advice
FRIDAY, Sept. 8, 2023 – Eczema and psoriasis are skin conditions that can each affect a person’s quality of life. The best way to know which one you have if you have an itchy rash or burning feeling ...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Plaque Psoriasis, Dermatological Disorders
Related drug support groups
prednisone, methylprednisolone, methotrexate, Humira, triamcinolone, clobetasol, fluocinonide, Remicade, prednisolone, view more... Stelara, Cosentyx, Skyrizi, adalimumab, etanercept, dexamethasone, desonide, halobetasol, Therapeutic